Sun Pharma Advanced Research Company Limited — Others, 10-01-2025: Certificate under SEBI (Depositories and Participants) Regulations, 2018

Sun Pharma Advanced Research Company has confirmed the receipt of a Certificate related to securities dematerialization for the quarter ended December 31, 2024. This certificate, issued by MUFG Intime India Pvt. Ltd., verifies that all securities submitted for dematerialization have been processed and listed on the relevant stock exchanges. Notably, there were no requests for rematerialization during this period.

This update reinforces the company's operational efficiency in managing its shares, which may enhance investor confidence. Overall, this suggests a stable environment for current and potential shareholders, supporting a positive outlook for the company.